SOX4 and breast carcinoma: MiR-320d was also downregulated in breast cancer tissues and can be used as an independent predictor of prognosis in breast cancer, miR-320d and HNF1A-AS1 competitively bind SOX4 to inhibit the progression of breast cancer (28).